WOWSMarket terminal

Novartis AG (NOVN)

the SIX Swiss Exchange · SIX:NOVN

Market open

117.44CHF+1.10 (+0.95%)Closes in 1h 53m

About NOVN

Novartis AG (NOVN) trades on the SIX Swiss Exchange in CHF, last at 117.44 — up 0.95% on the day. Regular trading hours on the SIX Swiss Exchange run 09:00–17:30 local time.

Novartis AG (NOVN) trades on the SIX Swiss Exchange in CHF, last at 117.44 — up 0.95% on the day. Regular trading hours on the SIX Swiss Exchange run 09:00–17:30 local time.

Day range: 116.62–118.28
52-week range: 97.05–132.68
Volume: 1.13M

Day range: 116.62–118.28
52-week range: 97.05–132.68
Volume: 1.13M

Candlestick Chart

Primary interactive technical chart with indicators

Market Coverage$NOVN

Institutional wire & real-time sentiment

Stocktwits·2d ago

market action

Stocktwits Biotech Dealmaker — Novartis, Sanofi And Novo Sign Week’s Biggest Deals

Real-time market wire coverage for $NOVN

grafa.com·2d ago

company

Novartis signs $7.8 billion Abogen RNA licensing deal

Real-time market wire coverage for $NOVN

BioPharma Dive·2d ago

market action

Novartis wagers almost $8B on a Chinese biotech’s RNA drugs

Real-time market wire coverage for $NOVN

Quartz·2d ago

market action

Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal

Real-time market wire coverage for $NOVN

The Wall Street Journal·3d ago

High

Novartis to License Drug From China’s Abogen in Up to $7.8 Billion Deal

Real-time market wire coverage for $NOVN

AD HOC NEWS·3d ago

company

Goldman Sachs raises target for Novartis stock to CHF 113.00

Real-time market wire coverage for $NOVN

marketscreener.com·3d ago

company

Novartis strikes up to $7.8 billion mRNA deal with China's Abogen

Real-time market wire coverage for $NOVN

InvestorsHub·3d ago

market action

Novartis Signs RNA Therapy Licensing Deal With China’s Abogen Worth Up to $7.8 Billion

Real-time market wire coverage for $NOVN

MT Newswires·3d ago

market action

Novartis, Abogen Sign RNA Licensing Agreement Worth up to $7.2 Billion

Real-time market wire coverage for $NOVN

PR Newswire·3d ago

market action

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs

Real-time market wire coverage for $NOVN

The Globe and Mail·3d ago

company

RBC Capital Remains a Hold on Novartis AG (NOVN)

Real-time market wire coverage for $NOVN

marketscreener.com·4d ago

company

Novartis AG : Receives a Sell rating from Goldman Sachs

Real-time market wire coverage for $NOVN

Simply Wall Street·5d ago

company

Novartis (SWX:NOVN) Puts Remibrutinib In Focus As Its Undervalued Case Holds

Real-time market wire coverage for $NOVN

Baseline & Trend Chart

Momentum baseline relative to reference price

Technical Analysis

Oscillators, moving averages & summary

Company Profile

Corporate structure, leadership & operations

Financials

Income statement & balance sheet

Compare NOVN.SW with another symbol Today's market movers